Schedule 13G ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Common Stock, par value $0.0001 per share · CUSIP: 76152G100

Event date: 2025-09-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • 683 CAPITAL MANAGEMENT, LLC

    Shares: 5,435,000.00 · Class: 5.36%

  • 683 CAPITAL PARTNERS, LP

    Shares: 5,435,000.00 · Class: 5.36%

  • Zweiman Ari

    Shares: 5,435,000.00 · Class: 5.36%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-002634
Form type
SCHEDULE 13G
Filer
683 Capital Management, LLC
CIK
CIK 1404574
Filed
Sep 29, 2025
Reporting period
Sep 22, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub